Company profile: PharmaDiagnostics
1.1 - Company Overview
Company description
- Provider of analytical techniques and assay systems to accelerate the drug discovery process, offering human albumin binding, human orosomucoid, membrane, and redox potential assays, plus experimental pKa, experimental log D, P-glycoprotein interaction, and Cytochromes P450 assays.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PharmaDiagnostics
3D Matrix
HQ: United States
Website
- Description: Provider of peptide technology medical devices, serving healthcare providers, research scientists and patients with therapy, endoscopic, laboratory and cardiac solutions. Portfolio includes PuraStat, PuraBond and PuraShield—synthetic haemostatic peptide hydrogels in prefilled syringes to manage bleeding in surgical procedures, including gastrointestinal endoscopic and ENT surgeries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3D Matrix company profile →
Atomic Alchemy
HQ: United States
Website
- Description: Provider of radioisotopes for medical, research, exploration, and industrial use, aiming to establish a reliable domestic supply in the U.S. for medical radioisotopes such as molybdenum-99, in a market that currently lacks a dedicated domestic supplier and relies on university research reactors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atomic Alchemy company profile →
Nanopoint Imaging
HQ: United States
Website
- Description: Provider of unique cellular experimentation systems for the life sciences market, offering a microfluidics platform that enables multi-day experimentation in a controlled environment and integrates with live cell imaging for greater precision.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanopoint Imaging company profile →
Validair
HQ: United Kingdom
Website
- Description: Provider of particle counters, sensors, and environmental monitoring solutions; clean air testing, calibration, and technical services; performance testing for cleanrooms, operating theatres, containment suites, LEVS, and workstations to ensure compliance; GMP consultancy on validation and qualification; ongoing re-qualification, routine monitoring, maintenance; and chlorine dioxide dry gas decontamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Validair company profile →
B-MoGen
HQ: United States
Website
- Description: Provider of genome engineering solutions, including the TcBuster Transposon System, a non-viral genetic modification method for delivering therapeutic payloads to diverse cell types, enabling rapid transgenic mammalian cell generation, multigene transfer, and CRISPR-mediated knockouts; and ScaleReady, a partnership that reduces complexity and cost in immune cell therapy and supports scalable immune cell expansion with platform, process, and product continuity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full B-MoGen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PharmaDiagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PharmaDiagnostics
2.2 - Growth funds investing in similar companies to PharmaDiagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PharmaDiagnostics
4.2 - Public trading comparable groups for PharmaDiagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →